ZNF213

gene
On this page

Also known as CR53ZKSCAN21ZSCAN53

Summary

ZNF213 (zinc finger protein 213, HGNC:13005) is a protein-coding gene on chromosome 16p13.3, encoding Zinc finger protein 213 (O14771). May be involved in transcriptional regulation.

C2H2 zinc finger proteins, such as ZNF213, have bipartite structures in which one domain binds DNA or RNA and the other modulates target gene expression.

Source: NCBI Gene 7760 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 97 total
  • MANE Select transcript: NM_004220

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:13005
Approved symbolZNF213
Namezinc finger protein 213
Location16p13.3
Locus typegene with protein product
StatusApproved
AliasesCR53, ZKSCAN21, ZSCAN53
Ensembl geneENSG00000085644
Ensembl biotypeprotein_coding
OMIM608387
Entrez7760

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 6 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay

ENST00000396878, ENST00000572647, ENST00000573771, ENST00000574575, ENST00000574902, ENST00000574928, ENST00000576416, ENST00000576863

RefSeq mRNA: 2 — MANE Select: NM_004220 NM_001134655, NM_004220

CCDS: CCDS10495

Canonical transcript exons

ENST00000396878 — 6 exons

ExonStartEnd
ENSE0000177849931350293135387
ENSE0000220320031371663137679
ENSE0000267394831406893142804
ENSE0000357265131387453138818
ENSE0000364638531389753139098
ENSE0000375019731384183138541

Expression profiles

Bgee: expression breadth ubiquitous, 251 present calls, max score 96.46.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.0502 / max 41.6971, expressed in 1663 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
1524002.07231306
1523971.1340643
1523980.7539477
1523990.090023

Top tissues by expression

255 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
spermCL:000001996.46gold quality
cardiac muscle of right atriumUBERON:000337994.07silver quality
left ventricle myocardiumUBERON:000656693.20silver quality
parotid glandUBERON:000183191.48gold quality
myocardiumUBERON:000234990.59silver quality
kidney epitheliumUBERON:000481990.02silver quality
tendon of biceps brachiiUBERON:000818889.95gold quality
right testisUBERON:000453487.69gold quality
cerebellar vermisUBERON:000472087.58gold quality
left testisUBERON:000453387.45gold quality
endothelial cellCL:000011587.31silver quality
nasal cavity epitheliumUBERON:000538486.75silver quality
upper arm skinUBERON:000426386.51gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451186.26silver quality
ileal mucosaUBERON:000033186.25gold quality
lateral globus pallidusUBERON:000247686.06gold quality
testisUBERON:000047386.00gold quality
quadriceps femorisUBERON:000137785.68silver quality
vastus lateralisUBERON:000137985.07silver quality
gingival epitheliumUBERON:000194985.04silver quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099184.93gold quality
lower lobe of lungUBERON:000894984.85gold quality
epithelial cell of pancreasCL:000008384.49gold quality
gingivaUBERON:000182884.40gold quality
substantia nigra pars reticulataUBERON:000196684.01gold quality
entorhinal cortexUBERON:000272883.92gold quality
lateral nuclear group of thalamusUBERON:000273683.63gold quality
gastrocnemiusUBERON:000138883.36gold quality
cortical plateUBERON:000534383.23gold quality
superficial temporal arteryUBERON:000161483.17gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-MTAB-4850no4.44
E-ANND-3no2.92

Regulation

Is transcription factor: yes

JASPAR motifs

MotifNameFamily
MA2121.1ZNF213More than 3 adjacent zinc fingers

JASPAR matrix evidence (PMIDs): PMID:27852650

miRNA regulators (miRDB)

67 targeting ZNF213, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4481100.0066.421669
HSA-MIR-3134100.0066.43777
HSA-MIR-4283100.0066.422097
HSA-MIR-4533100.0069.482758
HSA-MIR-6851-5P100.0065.631294
HSA-MIR-371A-3P99.9966.7791
HSA-MIR-453499.9966.581907
HSA-MIR-4745-5P99.9865.951028
HSA-MIR-512-3P99.9767.351049
HSA-MIR-807599.9767.20962
HSA-MIR-448799.9664.581252
HSA-MIR-808299.9567.271170
HSA-MIR-6753-3P99.9366.57637
HSA-MIR-7107-3P99.9366.73627
HSA-MIR-4671-3P99.8872.461045
HSA-MIR-3151-5P99.8663.831069
HSA-MIR-10395-5P99.8667.35676
HSA-MIR-520F-3P99.8271.321216
HSA-MIR-3934-3P99.7665.511351
HSA-MIR-6794-5P99.7666.381048
HSA-MIR-6752-3P99.7266.711587
HSA-MIR-182599.7268.111089
HSA-MIR-1296-3P99.7264.04636
HSA-MIR-4716-3P99.6966.731022
HSA-MIR-320299.6667.702737
HSA-MIR-6848-3P99.6466.49885
HSA-MIR-9851-3P99.6369.681110
HSA-MIR-613299.6065.831554
HSA-MIR-6836-5P99.6065.621538
HSA-MIR-608199.4866.071446

Literature-anchored findings (GeneRIF, showing 1)

  • ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling. (PMID:33939216)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusZfp213ENSMUSG00000071256
rattus_norvegicusZfp213ENSRNOG00000021872

Paralogs (30): ZNF263 (ENSG00000006194), ZNF500 (ENSG00000103199), ZKSCAN1 (ENSG00000106261), ZNF205 (ENSG00000122386), ZSCAN9 (ENSG00000137185), PGBD1 (ENSG00000137338), ZNF215 (ENSG00000149054), ZSCAN12 (ENSG00000158691), ZNF394 (ENSG00000160908), ZNF75A (ENSG00000162086), ZSCAN21 (ENSG00000166529), ZNF232 (ENSG00000167840), ZNF24 (ENSG00000172466), ZNF449 (ENSG00000173275), ZSCAN4 (ENSG00000180532), ZSCAN22 (ENSG00000182318), ZNF75D (ENSG00000186376), ZNF396 (ENSG00000186496), ZNF397 (ENSG00000186812), ZSCAN30 (ENSG00000186814), ZKSCAN4 (ENSG00000187626), ZSCAN23 (ENSG00000187987), ZKSCAN3 (ENSG00000189298), ZSCAN16 (ENSG00000196812), ZSCAN25 (ENSG00000197037), ZSCAN26 (ENSG00000197062), ZNF165 (ENSG00000197279), ZKSCAN8 (ENSG00000198315), ZSCAN31 (ENSG00000235109), ZNF853 (ENSG00000236609)

Protein

Protein identifiers

Zinc finger protein 213O14771 (reviewed: O14771)

Alternative names: Putative transcription factor CR53, Zinc finger protein with KRAB and SCAN domains 21

All UniProt accessions (6): O14771, A0A0S2Z4L6, I3L1Z4, I3L216, I3L2V8, I3L473

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Tissue specificity. Widely expressed with highest levels in testis.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

Isoforms (2)

UniProt IDNamesCanonical?
O14771-11yes
O14771-22

RefSeq proteins (2): NP_001128127, NP_004211* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR003309SCAN_domDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily
IPR038269SCAN_sfHomologous_superfamily
IPR050717C2H2-ZF_Transcription_RegFamily

Pfam: PF00096, PF01352, PF02023, PF13465

UniProt features (12 total): zinc finger region 5, domain 2, splice variant 2, chain 1, sequence conflict 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-O14771-F166.130.28

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 77 (showing top): GTGCCTT_MIR506, IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR, SANSOM_APC_MYC_TARGETS, SANSOM_APC_TARGETS_REQUIRE_MYC, NIKOLSKY_BREAST_CANCER_16P13_AMPLICON, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, KATSANOU_ELAVL1_TARGETS_DN, AKT_UP.V1_DN, MTOR_UP.V1_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CBX7_TARGET_GENES, CEBPZ_TARGET_GENES, DLX4_TARGET_GENES, E2F2_TARGET_GENES, FEV_TARGET_GENES

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
RNA polymerase II transcription regulatory region sequence-specific DNA binding2
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
cis-regulatory region sequence-specific DNA binding1
chromatin1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
nucleic acid binding1
binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

492 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF213OR1F1O43749447
ZNF213PSPC1Q8WXF1441
ZNF213NONOP30807432
ZNF213THUMPD3Q9BV44431
ZNF213TIGD7Q6NT04419
ZNF213SFPQP23246396
ZNF213GABPAQ06546395
ZNF213PAGR1Q9BTK6379
ZNF213PKIBQ9C010352
ZNF213TRNAU1APQ9NX07337
ZNF213RNF187Q5TA31325
ZNF213RNF181Q9P0P0321
ZNF213GDE1Q9NZC3319
ZNF213PDZK1Q5T2W1309
ZNF213RNF31Q96EP0301

IntAct

44 interactions, top by confidence:

ABTypeScore
ZNF213ZSCAN21psi-mi:“MI:0915”(physical association)0.670
ZNF213SCAND1psi-mi:“MI:0915”(physical association)0.670
ZNF397ZNF213psi-mi:“MI:0914”(association)0.640
ZNF213LNX1psi-mi:“MI:0915”(physical association)0.560
ZNF213FBXO17psi-mi:“MI:0915”(physical association)0.560
ZNF213EEF2KMTpsi-mi:“MI:0915”(physical association)0.560
ZNF213LMO4psi-mi:“MI:0915”(physical association)0.560
ZNF213PPLpsi-mi:“MI:0915”(physical association)0.560
ZSCAN32ZNF197psi-mi:“MI:0914”(association)0.530
ZNF397ZNF197psi-mi:“MI:0914”(association)0.530
ZKSCAN4ZNF213psi-mi:“MI:0914”(association)0.530
PGBD1ZNF213psi-mi:“MI:0914”(association)0.530
ZNF213ZNF24psi-mi:“MI:0914”(association)0.530
ZNF213CFTRpsi-mi:“MI:0915”(physical association)0.370
ZSCAN20ZNF197psi-mi:“MI:0914”(association)0.350
ZNF232ZNF197psi-mi:“MI:0914”(association)0.350
ZSCAN1ZNF213psi-mi:“MI:0914”(association)0.350
ZNF213DDX3Xpsi-mi:“MI:0914”(association)0.350
ZKSCAN8ZNF320psi-mi:“MI:0914”(association)0.350
MZF1ZNF213psi-mi:“MI:0914”(association)0.350
ZNF213BMP1psi-mi:“MI:0914”(association)0.350
TGIF2ZNF213psi-mi:“MI:0914”(association)0.350
LNX1ZNF213psi-mi:“MI:0915”(physical association)0.000

BioGRID (42): ZNF213 (Affinity Capture-MS), ZNF213 (Affinity Capture-MS), ZNF213 (Affinity Capture-MS), ZNF213 (Affinity Capture-MS), ZNF213 (Affinity Capture-MS), ZNF213 (Affinity Capture-MS), ZNF213 (Affinity Capture-MS), ZNF213 (Affinity Capture-MS), ZNF213 (Affinity Capture-MS), ZNF213 (Affinity Capture-MS), ZNF213 (Affinity Capture-MS), ZNF213 (Two-hybrid), EEF2KMT (Two-hybrid), PPL (Two-hybrid), LMO4 (Two-hybrid)

ESM2 similar proteins: A0A087WVF3, A0A087WXS9, A0A087X179, A0A087X1G2, A6NDS4, A6NER0, A6QPT6, B9A6J9, M3WHG5, O14771, O15482, O15553, O19110, O76081, P0C7X1, P0C7X3, P0C7X4, P35125, P48778, P48967, P79209, Q13670, Q15697, Q2TBC4, Q3T191, Q3UZD7, Q4R2Z8, Q5DRQ5, Q5SSQ6, Q5XFX8, Q69ZB3, Q6DHY5, Q6IPX1, Q6ZMN8, Q8BLR5, Q8BWA8, Q8IYF1, Q8IZP1, Q8JZW5, Q8N7G0

Diamond homologs: A1YEP8, A1YEQ3, A1YEV9, A1YFW2, A1YFW6, A1YG26, A1YG48, A1YG60, A1YGJ4, A1YGK6, A2T6E3, A2T6V8, A2T6W2, A2T712, A2T736, A2T7D2, A2T7D7, A2T7F2, A2T7F4, A2T7L7, A2T812, A6QNZ0, A6QPT6, B2KFW1, O14709, O14771, O14978, O15535, O43309, O60304, O95125, P10073, P17022, P17028, P17029, P17040, P28698, P49910, P51815, P59923

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

97 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance72
Likely benign10
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

1300 predictions. Top by Δscore:

VariantEffectΔscore
16:3135059:G:GTdonor_gain1.0000
16:3137676:ACAGG:Adonor_loss1.0000
16:3137678:AGGT:Adonor_loss1.0000
16:3137680:G:GCdonor_loss1.0000
16:3137681:T:Gdonor_loss1.0000
16:3138412:GCACA:Gacceptor_loss1.0000
16:3138413:CACA:Cacceptor_loss1.0000
16:3138414:ACAG:Aacceptor_gain1.0000
16:3138415:CA:Cacceptor_loss1.0000
16:3138416:A:AGacceptor_gain1.0000
16:3138416:AG:Aacceptor_gain1.0000
16:3138417:G:GCacceptor_loss1.0000
16:3138417:G:GGacceptor_gain1.0000
16:3138417:GG:Gacceptor_gain1.0000
16:3138417:GGAT:Gacceptor_gain1.0000
16:3138537:TAGCG:Tdonor_gain1.0000
16:3138538:AGCG:Adonor_gain1.0000
16:3138539:GCG:Gdonor_gain1.0000
16:3138539:GCGG:Gdonor_gain1.0000
16:3138540:CG:Cdonor_gain1.0000
16:3138540:CGGTG:Cdonor_loss1.0000
16:3138541:GG:Gdonor_gain1.0000
16:3138541:GGT:Gdonor_loss1.0000
16:3138542:G:GAdonor_loss1.0000
16:3138542:G:GGdonor_gain1.0000
16:3138546:G:GGdonor_gain1.0000
16:3138743:A:AGacceptor_gain1.0000
16:3138744:G:GGacceptor_gain1.0000
16:3138744:GCCC:Gacceptor_gain1.0000
16:3138744:GCCCA:Gacceptor_gain1.0000

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000267260 (16:3139962 C>T), RS1000445393 (16:3133235 G>C,T), RS1000476568 (16:3133054 G>A), RS1000486670 (16:3134851 C>T), RS1000570780 (16:3134575 T>C), RS1000773259 (16:3143024 C>T), RS1001381950 (16:3140600 G>A,T), RS1001605999 (16:3142989 C>T), RS1001663519 (16:3135138 G>C), RS1001733177 (16:3134889 A>G), RS1001945149 (16:3136475 T>C), RS1002958448 (16:3136310 T>C), RS1003151959 (16:3141792 C>G), RS1003281531 (16:3142083 G>GC), RS1003384265 (16:3142725 G>A,T)

Disease associations

OMIM: gene MIM:608387 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST002119_1Metabolite levels (X-11787)9.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0005276hydroxy-leucine measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

19 total (human), top 19 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteincreases expression2
aristolochic acid Iincreases expression1
GSK-J4decreases expression1
dicrotophosincreases expression1
ferrous chloridedecreases expression1
4-aminophenylarsenoxideaffects binding, decreases reaction1
di-n-butylphosphoric acidaffects expression1
2-palmitoylglycerolincreases expression1
ICG 001increases expression1
abrineincreases expression1
Temozolomideincreases expression1
Sunitinibincreases expression1
Arsenic Trioxideaffects binding, decreases reaction1
Acetaminophenincreases expression1
Air Pollutantsincreases abundance, increases expression1
Benzo(a)pyreneincreases methylation1
Tobacco Smoke Pollutionincreases expression1
Urethaneincreases expression1
Particulate Matterincreases abundance, increases expression1

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_XW19HEK293 eGFP-ZNF213Transformed cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.